Journal article
1813P Phase I/II trial of oral EPI-7386 in combination with enzalutamide (enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects: Current phase I (PI) results
Authors
Laccetti AL; Chatta G; Kyriakopoulos C; Iannotti N; Hotte SJ; Markowski MC; Pili R; Vuky J; Zhang J; Saad F
Journal
Annals of Oncology, Vol. 34, , pp. s982–s983
Publisher
Elsevier
Publication Date
October 1, 2023
DOI
10.1016/j.annonc.2023.09.2761
ISSN
0923-7534